APA (7th ed.) Citation

Mei, J., Cai, Y., Chen, L., Wu, Y., Liu, J., Qian, Z., . . . Zhang, Y. (2023). The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer. British Journal of Cancer, 129(10), 1645. https://doi.org/10.1038/s41416-023-02432-6

Chicago Style (17th ed.) Citation

Mei, Jie, et al. "The Heterogeneity of Tumour Immune Microenvironment Revealing the CRABP2/CD69 Signature Discriminates Distinct Clinical Outcomes in Breast Cancer." British Journal of Cancer 129, no. 10 (2023): 1645. https://doi.org/10.1038/s41416-023-02432-6.

MLA (9th ed.) Citation

Mei, Jie, et al. "The Heterogeneity of Tumour Immune Microenvironment Revealing the CRABP2/CD69 Signature Discriminates Distinct Clinical Outcomes in Breast Cancer." British Journal of Cancer, vol. 129, no. 10, 2023, p. 1645, https://doi.org/10.1038/s41416-023-02432-6.